Liver Mets Lead to Lorlatinib
Encouraged by the positive prognosis shared previously on the blog , we plunged into activity, optimistically facing the daily ups and downs.( Activity Amusement & Adventure ) After barely two weeks, pain arose in Geoff’s left side which gradually worsened until it became entirely debilitating. ( Meandering Medical Musings ) Amazingly, recent changes in treatment have achieved the best outcome healthwise since Geoff’s diagnosis. ( This post ) Liver Mets Lead to Lorlatinib Early in November, a long-awaited CT scan on Geoff’s chest, abdomen and pelvis, provided the first direct comparison to the dismal picture of his initial cancer diagnosis four months earlier. In light of the inconclusive results from the last brain and spinal column MRIs plus the knowledge that continued treatment on the second generation targeted drug, Alectinib, depended on clear evidence of it’s effectiveness, we had hoped the CT scan would show definitive improvement. Disappointingly, although two of the...